WE.SPEED.
ARENSIA is the world’s only privately owned and operated early-phase patient clinic network, purpose-built to deliver proof-of-concept clinical trials in patients up to 50% faster and at substantially lower cost than traditional research models.
Our fully integrated model—combining owned clinics, dedicated research physicians, and access to large, diverse patient populations across oncology, chronic, and acute diseases—accelerates patient recruitment, trial execution, and decision-making, enabling sponsors to achieve critical development milestones faster than conventional approaches.
Phase I/ II/ PROOF OF CONCEPT patient trials, in own state-of-the-art research clinics
Project Management/Study Coordination
Regulatory Affairs (dossier preparation and submission to HA/EC, import/export of study medication, etc.)
Scientific advice for protocol development (medical considerations on all aspects of protocol development e.g. in/exclusion criteria, study design, logistical aspects, etc.)
ARENSIA collaborates with leading pharmaceutical companies worldwide, as well as numerous biotechnology firms.
Global and mid-sized full-service Clinical Research Organizations partner with ARENSIA clinics to conduct early-phase clinical trials with patient involvement. This collaboration allows pharmaceutical companies, bound by global outsourcing agreements with specific full-service CRO vendors, to benefit from ARENSIA's proficiency and efficiency.
Through collaboration with ARENSIA, our research partners have significantly reduced recruitment periods and the overall number of clinical trial sites/countries involved in a range of studies. This results in substantial financial savings throughout the project lifecycle.
ARENSIA offers satellite services through vetted vendors for medical writing, data management, biostatistics, central laboratory, and bio-analytical services, which can be recommended as needed.